What changed
Reuters reported on October 7, 2026 that Biohub says its Virtual Biology Initiative has reached $1.8 billion in investment and associated resources. The total includes Biohub’s April commitment and earlier federal funding, not solely new cash. Reuters reports $300 million jointly from Meta, Google DeepMind and Isomorphic Labs, plus more than $500 million from the Department of Energy over five years.
Why it matters
Biohub aims to generate data about how cells respond to changing conditions for predictive AI models. This could make coordinated biological measurements a larger shared research resource. Access will not be simultaneous: Biohub science chief Alex Rives told Reuters that commercial funders receive an embargo period before public release, while parallel government-funded work has no such restrictions.
The caveats
Biohub’s Rives expects a first dataset in about a year and accurate predictive models within five years. Those are forecasts, not demonstrated results; Reuters does not establish shorter drug-development timelines or specify how long commercial access embargoes will last.
Go to the source
The original evidence behind this story. Read it for yourself.
Editorial record
Based on Reuters reporting, including statements and forecasts from Biohub; no independent model-performance validation is presented.
AI-assisted reporting with automated source, novelty and image checks. Signal in Five is responsible for this publication. These checks can miss errors; no human review is claimed. The image is an editorial illustration, not evidence of the event.
Last updated .
Corrections
No corrections recorded.
Our corrections policy ↗